V. Bray

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

J. Crues, M. Weisman, D. Furst, 2007, Annals of the rheumatic diseases.

Rheumatoid arthritis, new standards of care: nursing implications of infliximab

V. Bray, S. Risley, M. Thomas, 2004 .

Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel.

D. Furst, M. Weinblatt, C. Bingham, 2007, Rheumatology.

The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients

V. Bray, B. Brady, J. Tkacz, 2018, Drugs in R&D.

1171MO PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

N. Girard, S. Peters, R. Fietkau, 2021, Annals of Oncology.